Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
603456 Zhejiang Jiuzhou Pharmaceutical
- 14.37
- -0.06-0.42%
Market Closed Dec 20 15:00 CST
12.86BMarket Cap18.45P/E (TTM)
14.53High14.32Low103.21KlotVolume14.45Open14.43Pre Close148.97MTurnover1.15%Turnover Ratio12.45P/E (Static)895.24MShares23.8852wk High1.53P/B12.86BFloat Cap11.8352wk Low15.87Limit Up895.24MShs Float61.86Historical High12.99Limit Down1.46%Amplitude3.10Historical Low0.50Dividend TTM14.43Avg Price53.81KlotAsk3.48%Div YieldTTM100Lot Size46.55KlotBid
Zhejiang Jiuzhou Pharmaceutical News
Implementation Notice of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on Cancelling Some Repurchased Shares
Legal Opinion of Zhejiang Tianze Law Firm on the Implementation of Repurchase and Cancellation of Restricted Shares by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (2022 Equity Incentive Plan)
Legal Opinion of Zhejiang Tianze Law Firm on the Implementation of Repurchase and Cancellation of Restricted Shares by Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (2021 Equity Incentive Plan)
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Equity Incentive Restricted Stock Repurchase and Cancellation Implementation Notice
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on cancellation of repurchased shares and notification to creditors of repurchase and cancellation of some restricted shares
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the sale of 25% shares of Fangda Pharmaceutical Technology (Suzhou) Co., Ltd.
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Regarding the Pledge of Part of the Shares by the Controlling Shareholder
Announcement on the change of purpose and cancellation of repurchased shares by Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Announcement on the adjustment of the restricted share buyback price by Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
The Legal Opinion of Zhejiang Tiance Law Firm Regarding the Termination of the Implementation of the 2022 Restricted Stock Incentive Plan of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Zhejiang Tian Ce Law Firm's Legal Opinion on the Termination of the 2021 Restricted Stock Incentive Plan of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on Termination of Implementation of the Company's 2021 and 2022 Restricted Stock Incentive Plans and Repurchase and Cancellation of Restricted Stocks.
Announcement on the completion of the implementation of the plan for some directors and senior management to increase shareholding in Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Announcement on the Implementation of Equity Distribution for the Year 2023 of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Legal opinion from Zhejiang Tiance Law Firm regarding the implementation of the repurchase and cancellation of restricted stocks in Zhejiang Jiuzhou Pharmaceutical Co., Ltd. in accordance with the 2021 stock-based incentive plan.
Legal Opinion on the Implementation of the Repurchase and Cancellation of Restricted Stocks in the Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Stock-based Incentive Plan (2022) by Zhejiang Tiance Law Firm.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. announces the cancellation of restricted stock-based incentive share buyback.
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on adjusting the total amount of cash dividends distributed in 2023
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. announcement on share repurchase implementation results and share changes
Announcement of the progress of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding
